Related Experiment Video
Updated: Jun 4, 2026

08:22
Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
Published on: September 15, 2018
MicroRNAs: redefining mechanisms in cardiac disease
1Center for Pharmacogenomics, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA. gdorn@dom.wustl.edu
Journal of Cardiovascular Pharmacology
|February 2, 2011
Summary
MicroRNAs (miRs) control cardiac development and stress response by regulating protein expression. Understanding these microRNAs offers new diagnostic and therapeutic strategies for heart conditions.
Area of Science:
- Cardiovascular Biology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRs) are key regulators of protein expression, inhibiting mRNA translation.
- Their targeting of multiple mRNAs with related functions provides nodal control in biological processes.
- The dynamic interplay between miRs and their targets complicates study but offers therapeutic potential.
Purpose of the Study:
- To review the biology of microRNAs in the context of the cardiac system.
- To highlight recent findings on microRNA control of cardiac development and myofiber identity.
- To illustrate the clinical implications of microRNA expression profiling.
Main Methods:
- Literature review of microRNA biology and function in the heart.
- Synthesis of recent research on microRNA-mediated gene regulation in cardiac development.
- Analysis of clinical data related to microRNA expression in cardiac diseases.
Main Results:
- MicroRNAs play a critical role in regulating cardiac development and maintaining myofiber identity.
- Dysregulation of specific microRNAs is linked to cardiac stress responses.
- MicroRNA expression profiling shows promise for clinical diagnostics and therapeutics.
Conclusions:
- MicroRNAs are essential regulators of cardiac function, development, and response to stress.
- Further research into microRNA-mRNA interactions can elucidate cardiac biology.
- MicroRNA-based diagnostics and therapeutics represent a promising frontier in cardiology.
